A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic heart function in mice with type 2 diabetes independent of its weight loss ...

In patients with proliferative diabetic retinopathy, treatment with anti–vascular endothelial growth factor (anti-VEGF) may offer a safer alternative to panretinal photocoagulation (PRP), leading to ...

Henagliflozin, a popular drug prescribed for type 2 diabetes, has demonstrated potential anti-aging effects in a recent study published in Cell Reports Medicine. Subscribe to our newsletter for the ...

A new study shows that analyzing T cells in blood samples could be used to select at-risk patients for type 1 diabetes preventive therapy. Scripps Research scientists have shown that analyzing a ...

A new study found that metformin, a commonly prescribed diabetes drug associated with moderate weight loss, stimulates production of lac-phe, a molecule abundant after exercise. An "anti-hunger" ...

At the 131st Congress of the French Society of Ophthalmology in Paris, France, the role of second-generation intravitreal anti-VEGF injections compared to corticosteroid injections in treating ...